Find the latest oncology news for your sub-specialty area
Adding trastuzumab (Herceptin) to standard adjuvant chemotherapy did not improve invasive disease–free survival for patients…
The retinoblastoma (RB) susceptibility gene was the first gatekeeper gene discovered for cancer. When it…
Contrast-enhanced digital mammography is comparable to breast MRI in evaluating residual breast cancer after neoadjuvant…
Prostate cancer is the most common cancer among males in the United States. Approximately, 180,000…
Cancer therapies are designed to kill tumour cells, but produce tumour cell debris in the…
Tumour-targeting nanoparticles loaded with a drug that makes cancer cells more vulnerable to chemotherapy’s toxicity…
Multiple myeloma is the second most common blood cancer in the United States. Thirty to…
Increasing the dose intensity of chemotherapy by either shortening the intervals between the cycles or…
A combination of pembrolizumab and trastuzumab, tested in patients with trastuzumab-resistant advanced HER2-positive breast cancer,…
People who inherit genetic changes which alter the function of their immune system are at…